This pathway REPLACES the current NG12 and DG30 guidance in your area and affects all patients aged 18 years and above with suspected LGI cancers.
This revised pathway includes expanded use of FIT, aligning to guidance from the British Society of Gastroenterology (BSG) and Association of Coloproctology of Great Britain & Ireland (ACPGBI), which is supported by NHSE and accredited by NICE. It is also underpinned by compelling evidence to support the use of FIT in conjunction with relevant blood tests, history and clinical examination to determine the appropriate referral or management pathway, improving the detection of cancers and improve patient experience.
To find out more and to access all FIT resources, click here.
